TABLE 6.
MSC-sEVs exert curative effects by optimizing fibroblast behavior.
| MSC source | Isolation | Target cells/conditions | Functional cargo | Molecules/Pathways affected | Key functions/Downstream genes | Ref |
|---|---|---|---|---|---|---|
| BM | Ultracentrifugation | cutaneous wound in rats; HaCaT, HDFs | — | TGF-β1↓→Smad2/3/4↓; TGF-β3↑, Smad7↑ | Improved anti-fibrotic and scar-less wound healing | Jiang et al. (2020a) |
| Menstrual blood | Ultracentrifugation | cutaneous wound in diabetic mice | — | Col1/Col3↓ | Reduced cellularity in granulation tissue and diminished scar formation | Dalirfardouei et al. (2019) |
| Modified synovium | Ultracentrifugation | cutaneous wound in diabetic rats; HDFs | MiR-126 | p-AKT↑, p-ERK1/2↑ | Accelerated re-epithelialization and collagen maturity in vivo; boosted migration and proliferation of HDFs | Tao et al. (2017) |
| AT | — | HDFs | miRs (-4484, -619-5p, -6879-5p) | Col Ⅰ↑, Elastin↑, KGF↑, CD34↑, VEGF↑ | Boosted proliferation and migration of HDFs | Choi et al. (2018) |
| BM | Polymer precipitation and ultracentrifugation | HDFs | Wnt3a | — | promoted proliferation and migration abilities | McBride et al. (2017) |
| Fetal dermal | Polymer precipitation | skin wounds in mice; HDFs | Jagged 1 | Notch 1↑ → Hes 1↑→ PCNA↑, CK19↑ | Promoted proliferation, migration and secretion abilities in vitro and in vivo | Wang et al. (2019a) |
| BM | Ultracentrifugation | 3D human Skin Organotypic model; HDFs, HaCaT | — | — | Faster re-epithelialization; enhanced proliferation and migratory capacity in vitro | Tutuianu et al. (2021) |
| Murine BM | ultracentrifugation | DFU model in mice; HDF | LncRNA H19 | miR-152-3p↓ → PTEN↑ → p85PI3K↓→p-AKT↓ | Improved proliferation and migration and suppressed apoptosis in vitro and in vivo | Li et al. (2020) |
| Thrombin pretreated hucb | Ultracentrifugation | cutaneous wound in rats; HDFs | angiogenin, angiopoietin-1, HGF, VEGF | p-ERK1/2↑, p-AKT↑ | elevated proliferation and migration activity of HDFs; faster wound healing in vivo | Sung et al. (2019) |
| Huc | Ultracentrifugation | HDFs; skin wounds in mice | miR-21, -23a, -125b, -145 | TGF-β2↓, Smad2↓ | Suppression of myofibroblasts transformation or scar formation | Fang et al. (2016) |
| Huc | Ultracentrifugation | HaCATs, MDF; second-degree burn in rats | 14-3-3ζ | YAP + p-LAS → p-YAP↑, cytoplasmic retention of YAP↑, a-SMA↓, col I↓ and col III↓ | Reduced skin cell proliferation and nuclear translocation of β-catenin under high cell density in vitro; restricted excessive cell expansion and collagen deposition during remodeling period in vivo | Zhang et al. (2016) |
| AT | Polymer precipitation | skin wounds in mice; HDF | ERK/MAPK↑→MMP3/TIMP1↑, TGF-β3/TGF-β1↑, Col Ⅲ/Col Ⅰ↑ | Mitigated myofibroblast differentiation; optimized ECM remodeling and lessened scar formation in vivo | Wang et al. (2017) | |
| TSG-6 modified BM | Polymer precipitation | skin wounds in mice | TSG-6 | TGF-β1↓, p-SMAD2Ser467/3S423/S425↓→ col I↓, col III↓, α-SMA↓; MCP-1↓, TNF-α↓, IL-1β↓, IL-6 | prevented inflammation and collagen deposition, restricted scar formation in vivo | Jiang et al. (2020b) |
| Huc | ultracentrifugation | Skin wound in rats; HDF | miR-21-5p, -125b-5p | TGFBR1↓, TGFBR2↓, α-SMA↓, collagen I↓ | Suppressed myofibroblast differentiation and scar formation, improved regenerative healing | Zhang et al. (2021) |
BM, bone marrow; HaCaT, human immortal keratinocyte line; HDF, human dermal fibroblast; TGF-β, transgenic growth factor β; Huc, human umbilical cord; MDFs, mouse dermal fibroblasts; YAP, Yes-associated protein; LAS, large tumor suppressor; AT, adipose tissue; Erk, extracellular regulated kinase; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; MCP, monocyte chemoattractant protein-1; TNF-α, tumor necrosis factor-α; TGFBR, TGF-β, receptor type II.